Singapore, Singapore

Aradhana Upadhyay

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Santen Pharmaceutical Co., Ltd., Singapore Health Services Pte Ltd. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aradhana Upadhyay. Retrieved from https://idiyas.com/inventor/aradhana-upadhyay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aradhana Upadhyay: Innovator in Myopia Treatment

Introduction

Aradhana Upadhyay is a prominent inventor based in Singapore, known for her contributions to the field of ophthalmology. She has made significant strides in developing treatments aimed at preventing and managing myopia, a condition that affects millions worldwide.

Latest Patents

Her most notable patent is titled "Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient." This invention focuses on utilizing tiotropium to address myopia, showcasing her innovative approach to eye care. She holds 1 patent in this area.

Career Highlights

Aradhana has worked with reputable organizations, including Singapore Health Services Pte Ltd and Santen Pharmaceutical Co., Ltd. Her experience in these companies has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout her career, Aradhana has worked alongside notable colleagues such as Tiang Hwee Donald Tan and Roger Wilmer Beuerman. These collaborations have enriched her work and expanded her impact in the field of myopia treatment.

Conclusion

Aradhana Upadhyay's innovative work in myopia treatment exemplifies her dedication to improving eye health. Her contributions continue to influence the field and inspire future advancements in ophthalmology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…